These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15122304)

  • 1. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
    Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
    Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
    Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
    Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
    Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
    Misumi Y; Ando Y; Gonçalves NP; Saraiva MJ
    Lab Invest; 2013 Aug; 93(8):911-20. PubMed ID: 23817086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
    Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
    Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
    Ferreira N; Saraiva MJ; Almeida MR
    PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
    Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
    Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
    Koike H; Kiuchi T; Iijima M; Ueda M; Ando Y; Morozumi S; Tomita M; Kawagashira Y; Watanabe H; Katsuno M; Shimoyama Y; Okazaki Y; Kamei H; Sobue G
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1287-90. PubMed ID: 20935325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
    Tsuchiya-Suzuki A; Yazaki M; Sekijima Y; Kametani F; Ikeda S
    Amyloid; 2013 Sep; 20(3):156-63. PubMed ID: 23826783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
    Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
    J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.
    Yoshinaga T; Yazaki M; Sekijima Y; Kametani F; Miyashita K; Hachiya N; Tanaka T; Kokudo N; Higuchi K; Ikeda S
    J Pathol Clin Res; 2016 Apr; 2(2):72-9. PubMed ID: 27499917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
    Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Med Mol Morphol; 2005 Sep; 38(3):142-54. PubMed ID: 16170462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
    Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
    Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of de novo amyloidosis in recipients of domino liver transplantation: 12 to 40 (mean 24) month follow-up.
    Bittencourt PL; Couto CA; Leitão RM; Siqueira SA; Farias AQ; Massarollo PC; Mies S
    Amyloid; 2002 Sep; 9(3):194-6. PubMed ID: 12408683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
    Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
    Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation.
    Misumi Y; Narita Y; Oshima T; Ueda M; Yamashita T; Tasaki M; Obayashi K; Isono K; Inomata Y; Ando Y
    Liver Transpl; 2016 May; 22(5):656-64. PubMed ID: 26600212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.